State Street Corp Celularity Inc Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.22 - $0.56 $11,616 - $29,568	52,800 Added 26.87%	249,300 $54,000
Q2 2023 Aug 14, 2023	SELL	$0.42 - $0.81 $264,225 - $509,577	-629,108 Reduced 76.2%	196,500 $104,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $7,408 - $15,214	13,230 Added 1.63%	825,608 $511,000
Q4 2022 Feb 14, 2023	BUY	$1.08 - $2.35 $219,632 - $477,903	203,363 Added 33.39%	812,378 $1.05 Million
Q3 2022 Nov 15, 2022	BUY	$0.43 - $4.31 $173,738 - $1.74 Million	404,042 Added 197.12%	609,015 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $575,974 - $2.65 Million	204,973 New	204,973 $697,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.